137 related articles for article (PubMed ID: 12962369)
21. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J
Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
[TBL] [Abstract][Full Text] [Related]
22. [Induction chemotherapy with cisplatin and peplomycin in squamous cell carcinoma of the head and neck].
Takagi T; Sakai C; Oguro M; Omura K; Shimada H; Takemiya S; Kuwahara T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):543-6. PubMed ID: 2434031
[No Abstract] [Full Text] [Related]
23. Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck.
Faivre S; Marti A; Rixe O; Janot F; Julieron M; Gatineau M; Temam S; Armand JP; Domenge C; Luboinski B; Raymond E
Head Neck; 2005 Apr; 27(4):311-9. PubMed ID: 15700290
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens.
Massa E; Dessì M; Gaspardini G; Saba F; Cherchi V; Mantovani G
Oral Oncol; 2010 Nov; 46(11):818-21. PubMed ID: 20920877
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
[TBL] [Abstract][Full Text] [Related]
27. Docetaxel and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results.
Airoldi M; Cattel L; Marchionatti S; Recalenda V; Pedani F; Tagini V; Bumma C; Beatrice F; Succo G; Maria Gabriele A
Am J Clin Oncol; 2003 Aug; 26(4):378-81. PubMed ID: 12902890
[TBL] [Abstract][Full Text] [Related]
28. Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
Herbst RS; Arquette M; Shin DM; Dicke K; Vokes EE; Azarnia N; Hong WK; Kies MS
J Clin Oncol; 2005 Aug; 23(24):5578-87. PubMed ID: 16009949
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant carboplatin and vinorelbine followed by chemoradiotherapy in locally advanced head and neck or oesophageal squamous cell carcinoma: a phase II study in elderly patients or patients with poor performance status.
Koussis H; Scola A; Bergamo F; Tonello S; Basso U; Karahontzitis P; Chiarion-Sileni V; Pasetto L; Ruol A; Loreggian L; Lora O; Bottin R; Marioni G; Donach M; Jirillo A
Anticancer Res; 2008; 28(2B):1383-8. PubMed ID: 18505084
[TBL] [Abstract][Full Text] [Related]
30. A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Espinosa E; Zamora P; Millá A; Morales S; Molina R; Mira M; González Barón M;
Head Neck; 2002 Dec; 24(12):1054-9. PubMed ID: 12454943
[TBL] [Abstract][Full Text] [Related]
31. [Results of primary chemotherapy in 44 patients with advanced squamous cell carcinoma in the area of the head and neck].
von Heyden HW; Schröder M; Scherpe A; Stennert E; Beyer JH; Nagel GA; Hoffmann H; Schneider B
HNO; 1984 Nov; 32(11):454-9. PubMed ID: 6210278
[TBL] [Abstract][Full Text] [Related]
32. Continuous intravenous infusion combination chemotherapy for head and neck squamous cell carcinoma.
Gonzalez MF; Valdivieso JG; Sartiano GP
Oncology; 1984; 41(6):377-82. PubMed ID: 6209601
[TBL] [Abstract][Full Text] [Related]
33. [2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine].
Schröder M; von Heyden HW; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Kastenbauer E; Westerhausen M; Schroeder M; Caliebe W; Rudert H; Lissers R; Hofmann J; Schneider B
Onkologie; 1983 Jun; 6(3):114-7. PubMed ID: 6193472
[TBL] [Abstract][Full Text] [Related]
34. Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study.
Fonseca E; Grau JJ; Sastre J; García-Gómez JM; Rueda A; Pastor M; Lara MA; Navalón M; Berrocal A; Tisaire JL; Cruz JJ
Eur J Cancer; 2005 Jun; 41(9):1254-60. PubMed ID: 15908196
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
[TBL] [Abstract][Full Text] [Related]
36. Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers.
Woods RL; Stewart J; Fox RM; Tattersall MH
Cancer Treat Rep; 1979; 63(11-12):1997-9. PubMed ID: 93514
[TBL] [Abstract][Full Text] [Related]
37. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemotherapy in multiple synchronous head and neck and esophagus squamous cell carcinomas.
Guillot T; Spielmann M; Kac J; Luboinski B; Tellez-Bernal E; Munck JN; Bachouchi M; Armand JP; Cvitkovic E
Laryngoscope; 1992 Mar; 102(3):311-9. PubMed ID: 1372059
[TBL] [Abstract][Full Text] [Related]
40. Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancer.
Hitt R; Hornedo J; Colomer R; Hidalgo M; Brandariz A; Peña M; Vicent JA; Cortés-Funes H
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-58-S2-64. PubMed ID: 9045339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
